Therefore, we share their view on the need of caution and propose that the clinical administration of recombinant IL15 alone could be efficient and sufficient in NK cell-mediated tumor eradication thus avoiding potentially immunostimulatory molecules generated by the combination of IL15Rα with IL15. This evidence concerns the gene IL15 and neoplasm.